Research output per year
Research output per year
Fingerprint
Dive into the research topics where James Eshleman is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
CRISPR-Cas9 for selective targeting of somatic mutations in pancreatic cancers
Teh, S. S. K., Bowland, K., Halper-Stromberg, E., Kotwal, A., Bennett, A., Skaist, A., Tang, J., Cai, F., Macoretta, A., Liang, H., Kamiyama, H., Wheelan, S., Lin, M. T., Hruban, R. H., Hung, C. F., Goldstein, M., Scharpf, R. B., Roberts, N. J. & Eshleman, J. R., Jun 1 2024, In: NAR Cancer. 6, 2, zcae028.Research output: Contribution to journal › Article › peer-review
Open Access -
High-Grade, Nonsarcomatoid Chromophobe Renal Cell Carcinoma: A Series of 22 Cases With Novel Molecular Features on a Subset
Baraban, E. G., Elias, R., Lin, M. T., Ged, Y., Zhu, J., Pallavajjala, A., Singla, N., Lotan, T. L., Argani, P., Eshleman, J. R. & Epstein, J., May 2024, In: Modern Pathology. 37, 5, 100472.Research output: Contribution to journal › Article › peer-review
-
Using a CA19-9 Tumor Marker Gene Test to Assess Outcome After Pancreatic Cancer Surgery
Ando, Y., Dbouk, M., Blackford, A. L., Yoshida, T., Saba, H., Abou Diwan, E., Yoshida, K., Sokoll, L., Eshleman, J. R., Burkhart, R., He, J. & Goggins, M., May 1 2024, In: Annals of surgical oncology. 31, 5, p. 2902-2912 11 p.Research output: Contribution to journal › Article › peer-review
-
Using Tumor Marker Gene Variants to Improve the Diagnostic Accuracy of DUPAN-2 and Carbohydrate Antigen 19-9 for Pancreatic Cancer
Ando, Y., Dbouk, M., Yoshida, T., Saba, H., Diwan, E. A., Yoshida, K., Dbouk, A., Blackford, A. L., Lin, M. T., Lennon, A. M., Burkhart, R. A., He, J., Sokoll, L., Eshleman, J. R., Canto, M. I. & Goggins, M., Jun 20 2024, In: Journal of Clinical Oncology. 42, 18, p. 2196-2206 11 p.Research output: Contribution to journal › Article › peer-review
Open Access -
A first-in-class pan-lysyl oxidase inhibitor impairs stromal remodeling and enhances gemcitabine response and survival in pancreatic cancer
Chitty, J. L., Yam, M., Perryman, L., Parker, A. L., Skhinas, J. N., Setargew, Y. F. I., Mok, E. T. Y., Tran, E., Grant, R. D., Latham, S. L., Pereira, B. A., Ritchie, S. C., Murphy, K. J., Trpceski, M., Findlay, A. D., Melenec, P., Filipe, E. C., Nadalini, A., Velayuthar, S. & Major, G. & 110 others, , Sep 2023, In: Nature Cancer. 4, 9, p. 1326-1344 19 p.Research output: Contribution to journal › Article › peer-review
Open Access